Yasuhiro Maejima
Overview
Explore the profile of Yasuhiro Maejima including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
123
Citations
4981
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kubo T, Sugiura K, Tokita Y, Takano H, Takamisawa I, Takayama M, et al.
Heart
. 2025 Mar;
PMID: 40037766
Background: The Japanese Hypertrophic Cardiomyopathy Registry Study was designed to provide comprehensive, real-world insights into the clinical characteristics and management of hypertrophic cardiomyopathy (HCM) in Japan. Methods: This multicentre, prospective...
2.
Sugihara T, Harigai M, Uchida H, Yoshifuji H, Maejima Y, Ishizaki J, et al.
Arthritis Res Ther
. 2025 Jan;
27(1):19.
PMID: 39891304
Objective: To evaluate the ability to discriminate giant cell arteritis (GCA) from Takayasu arteritis (TAK) according to the modified 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology (ACR/EULAR)...
3.
Uchida H, Nakaoka Y, Sugihara T, Yoshifuji H, Maejima Y, Watanabe Y, et al.
Circ J
. 2024 Sep;
PMID: 39261026
Background: This study aimed to clarify recent clinical features and treatment outcomes in Japanese patients with newly diagnosed Takayasu arteritis (TAK) during the first 2 years of treatment. Methods And...
4.
Hara M, Mandai S, Mori T, Maejima Y, Uchida S
Eur Heart J Case Rep
. 2024 Aug;
8(8):ytae347.
PMID: 39099888
Background: Takayasu arteritis is a large-vessel vasculitis that affects the aorta and its primary branches. Myocarditis is a rare life-threatening complication and potential diagnostic pitfall in patients with Takayasu arteritis....
5.
Maejima Y, Nah J, Aryan Z, Zhai P, Sung E, Liu T, et al.
Nat Commun
. 2024 Jul;
15(1):6279.
PMID: 39060225
The molecular mechanisms by which FoxO transcription factors mediate diametrically opposite cellular responses, namely death and survival, remain unknown. Here we show that Mst1 phosphorylates FoxO1 Ser209/Ser215/Ser218/Thr228/Ser232/Ser243, thereby inhibiting FoxO1-mediated...
6.
Nies M, Watanabe K, Kawamura I, Wang B, Litt J, Turovskiy R, et al.
Circ Arrhythm Electrophysiol
. 2024 May;
17(7):e012854.
PMID: 38758741
Background: Unlike conventional microsecond pulsed electrical fields that primarily target the cell membranes, nanosecond pulses are thought to primarily electroporate intracellular organelles. We conducted a comprehensive preclinical assessment of catheter-based...
7.
Abe Y, Fujii T, Miyawaki Y, Sugihara T, Uchida H, Maejima Y, et al.
Mod Rheumatol
. 2024 Apr;
34(6):1194-1201.
PMID: 38590042
Objectives: The aim is to access the real-world clinical management of physicians who treat Takayasu arteritis (TAK) and giant cell arteritis (GCA) after the publication of the Japanese Circulation Society...
8.
Kanno Y, Yonetsu T, Aoyama N, Shiheido-Watanabe Y, Yoshikawa H, Ohmori M, et al.
Am Heart J Plus
. 2024 Mar;
35:100325.
PMID: 38511177
[This corrects the article DOI: 10.1016/j.ahjo.2023.100298.].
9.
Kanno Y, Yonetsu T, Aoyama N, Shiheido-Watanabe Y, Yoshikawa H, Ohmori M, et al.
Am Heart J Plus
. 2024 Mar;
30:100298.
PMID: 38510923
Background: Periodontal disease (PD) is associated with an increased risk of cardiovascular disease (CVD). Pericardial adipose tissue (PAT) is known as a marker of progressive CVD. This study sought to...
10.
Yamada E, Umemoto T, Taguchi T, Onishi I, Yamamoto A, Tsukamoto K, et al.
JSES Int
. 2024 Mar;
8(2):349-354.
PMID: 38464439
Background: Cardiac amyloidosis is a fatal disease of severe heart failure caused by the accumulation of amyloid in the myocardium. This disease is often advanced by the time cardiac symptoms...